An Initial Injection and a Crossover Injection of Amniotic Suspension Allograft Following Failed Treatment with Hyaluronic Acid or Saline Are Equally Effective in the Treatment of Moderate Symptomatic Knee Osteoarthritis Over 12 Months.
暂无分享,去创建一个
B. Mandelbaum | J. Farr | S. Sherman | A. Gomoll | K. Mowry | K. Kimmerling | S. Tabet | W. T. Archambault
[1] B. Mandelbaum,et al. Safety and Efficacy of an Amniotic Suspension Allograft Injection over 12 Months in a Single-Blinded, Randomized Controlled Trial for Symptomatic Osteoarthritis of the Knee. , 2021, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[2] J. Farr,et al. Amniotic Product Treatments: Clinical and Basic Science Evidence , 2020, Current Reviews in Musculoskeletal Medicine.
[3] J. Farr,et al. Amniotic Suspension Allograft Modulates Inflammation in a Rat Pain Model of Osteoarthritis , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[4] J. Farr,et al. A Randomized Controlled Single-Blind Study Demonstrating Superiority of Amniotic Suspension Allograft Injection Over Hyaluronic Acid and Saline Control for Modification of Knee Osteoarthritis Symptoms , 2019, The Journal of Knee Surgery.
[5] Sean Tighe,et al. Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis: A Prospective, Single-Center Pilot Study , 2019, Pain medicine.
[6] P. Conaghan,et al. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis , 2019, Advances in Therapy.
[7] K. Paterson,et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. , 2019, Regenerative medicine.
[8] F. Vilchez-Cavazos,et al. Human amniotic membrane intra-articular injection prevents cartilage damage in an osteoarthritis model , 2018, Experimental and therapeutic medicine.
[9] G. Isbary,et al. Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] C. T. Vangsness,et al. The Placenta: Applications in Orthopaedic Sports Medicine , 2018, The American journal of sports medicine.
[11] Jeremy B. Vines,et al. Proteomic Comparison of Amnion and Chorion and Evaluation of the Effects of Processing on Placental Membranes. , 2017, Wounds : a compendium of clinical research and practice.
[12] Jeffrey B. Driban,et al. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial , 2017, JAMA.
[13] G. Guyatt,et al. Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations , 2017, BMJ Open.
[14] S. Tseng,et al. Efficacy of Particulate Amniotic Membrane and Umbilical Cord Tissues in Attenuating Cartilage Destruction in an Osteoarthritis Model. , 2016, Tissue engineering. Part A.
[15] N. Heckmann,et al. Application of Amniotic Tissue in Orthopedic Surgery. , 2016, American journal of orthopedics.
[16] B. Saltzman,et al. Human Amniotic Membrane–Derived Products in Sports Medicine , 2016, The American journal of sports medicine.
[17] J. Farr,et al. Cryopreserved Amniotic Suspension for the Treatment of Knee Osteoarthritis , 2015, Journal of Knee Surgery.
[18] F. Eckstein,et al. Contralateral Knee Effect on Self‐Reported Knee‐Specific Function and Global Functional Assessment: Data From the Osteoarthritis Initiative , 2015, Arthritis care & research.
[19] Dariusz Szukiewicz,et al. The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis , 2014, Mediators of inflammation.
[20] R. Guldberg,et al. Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development , 2014, Arthritis Research & Therapy.
[21] P. Stratford,et al. Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. , 2013, Rheumatology.
[22] K. Landorf,et al. Minimal Important Difference (MID) of two commonly used outcome measures for foot problems , 2010, Journal of foot and ankle research.
[23] M. Dougados,et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. , 2004, Osteoarthritis and cartilage.
[24] E. Roos,et al. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis , 2003, Health and quality of life outcomes.
[25] P. Bijur,et al. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. , 2001, Annals of emergency medicine.
[26] M. Goldring,et al. Osteoarthritis and cartilage: The role of cytokines , 2000, Current rheumatology reports.
[27] S. Z. Zhao,et al. Evaluation of the Functional Status Aspects of Health‐Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib , 1999, Pharmacotherapy.
[28] J. Kellgren,et al. Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.